These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8042406)

  • 1. [Study on the influence of enzymatic digestion upon tumor-infiltrating lymphocytes].
    Li BR; Tong SQ; Hu BY; Zhu YM; Zhang XH; Wu JH; Lu J; Lu DY
    Shi Yan Sheng Wu Xue Bao; 1994 Mar; 27(1):103-7. PubMed ID: 8042406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new experimental and clinical approach of combining usage of highly active tumor-infiltrating lymphocytes and highly sensitive antitumor drugs for the advanced malignant tumor.
    Li BR; Tong SQ; Zhang XH; Lu J; Gu QL; Lu DY
    Chin Med J (Engl); 1994 Nov; 107(11):803-7. PubMed ID: 7867384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.
    Lefor AT; Fabian DF
    J Surg Res; 1998 Feb; 75(1):49-53. PubMed ID: 9614856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tumor-infiltrating lymphocytes from murine mammary adenocarcinomas.
    Ames IH; Gagne GM; Weiner DL; Tice DG
    Anticancer Res; 1994; 14(3A):881-8. PubMed ID: 8074488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficient isolation of chondrocytes from rabbit articular cartilage with three-step enzymatic digestion and observation of their biological characteristics during cultivation in vitro].
    Zhou Q; Li QH; Dai G; Shi GH
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(8):522-6. PubMed ID: 15938912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients.
    Schöndorf T; Engel H; Kurbacher CM; Brenne U; Kolhagen H; Göhring UJ; Scharl A; Mallmann P
    J Soc Gynecol Investig; 1998; 5(2):102-7. PubMed ID: 9509389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts of tumor-infiltrating lymphocytes in human malignancies.
    Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H
    J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and expansion of tumor infiltrating lymphocytes of digestive system in vitro and their cytotoxicity.
    Chen DD; Tan QF; Tao KX
    J Tongji Med Univ; 1995; 15(4):220-2, 226. PubMed ID: 8731928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.
    Dadmarz RD; Ordoubadi A; Mixon A; Thompson CO; Barracchini KC; Hijazi YM; Steller MA; Rosenberg SA; Schwartzentruber DJ
    Cancer J Sci Am; 1996; 2(5):263-72. PubMed ID: 9166543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of CDDP on cytotoxicity of TILs obtained from colorectal tumors].
    Xu Z; Qi X; Liu F
    Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):265-7. PubMed ID: 10374556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.
    Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC
    Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
    Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.